141 related articles for article (PubMed ID: 23143188)
21. International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies.
Bolon B; Barale-Thomas E; Bradley A; Ettlin RA; Franchi CA; George C; Giusti AM; Hall R; Jacobsen M; Konishi Y; Ledieu D; Morton D; Park JH; Scudamore CL; Tsuda H; Vijayasarathi SK; Wijnands MV
Exp Toxicol Pathol; 2011 Jan; 63(1-2):187-95. PubMed ID: 20724123
[TBL] [Abstract][Full Text] [Related]
22. Commentary: the role of the toxicologic pathologist in academia.
Turner PV; Haschek WM; Bolon B; Diegel K; Hayes MA; McEwen B; Sargeant AM; Scudamore CL; Stalker M; von Beust B; Wancket LM
Vet Pathol; 2015 Jan; 52(1):7-17. PubMed ID: 24554401
[TBL] [Abstract][Full Text] [Related]
23. Strategic importance of research support through pathology.
Cockerell GL; McKim JM; Vonderfecht SL
Toxicol Pathol; 2002; 30(1):4-7. PubMed ID: 11890474
[TBL] [Abstract][Full Text] [Related]
24. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
25. Toxicologic pathology in the new millennium.
Ettlin RA; Leininger JR
Toxicol Pathol; 2002; 30(1):160-3. PubMed ID: 11890471
[No Abstract] [Full Text] [Related]
26. Recent developments in preclinical toxicological pathology.
Finch JM
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):209-13. PubMed ID: 15982689
[TBL] [Abstract][Full Text] [Related]
27. On-target and off-target-based toxicologic effects.
Rudmann DG
Toxicol Pathol; 2013 Feb; 41(2):310-4. PubMed ID: 23085982
[TBL] [Abstract][Full Text] [Related]
28. The state of the art of the zebrafish model for toxicology and toxicologic pathology research--advantages and current limitations.
Spitsbergen JM; Kent ML
Toxicol Pathol; 2003; 31 Suppl(Suppl):62-87. PubMed ID: 12597434
[TBL] [Abstract][Full Text] [Related]
29. Practical Applications of in Vivo and ex Vivo MRI in Toxicologic Pathology Using a Novel High-performance Compact MRI System.
Tempel-Brami C; Schiffenbauer YS; Nyska A; Ezov N; Spector I; Abramovitch R; Maronpot RR
Toxicol Pathol; 2015 Jul; 43(5):633-50. PubMed ID: 25694086
[TBL] [Abstract][Full Text] [Related]
30. Complementary roles for toxicologic pathology and mathematics in toxicogenomics, with special reference to data interpretation and oscillatory dynamics.
Morgan KT; Pino M; Crosby LM; Wang M; Elston TC; Jayyosi Z; Bonnefoi M; Boorman G
Toxicol Pathol; 2004; 32 Suppl 1():13-25. PubMed ID: 15209399
[TBL] [Abstract][Full Text] [Related]
31. Toxicogenomics, drug discovery, and the pathologist.
Boorman GA; Anderson SP; Casey WM; Brown RH; Crosby LM; Gottschalk K; Easton M; Ni H; Morgan KT
Toxicol Pathol; 2002; 30(1):15-27. PubMed ID: 11890469
[TBL] [Abstract][Full Text] [Related]
32. Approaches to advancing quantitative human health risk assessment of environmental chemicals in the post-genomic era.
Chiu WA; Euling SY; Scott CS; Subramaniam RP
Toxicol Appl Pharmacol; 2013 Sep; 271(3):309-23. PubMed ID: 20353796
[TBL] [Abstract][Full Text] [Related]
33. Do we need a "Chair of alternative methods", and where?
Wendel A
ALTEX; 2002; 19(2):64-8. PubMed ID: 12098011
[TBL] [Abstract][Full Text] [Related]
34. The future of regulatory toxicology: impact of the biotechnology revolution.
MacGregor JT
Toxicol Sci; 2003 Oct; 75(2):236-48. PubMed ID: 12883082
[TBL] [Abstract][Full Text] [Related]
35. The future of environmental and toxicologic pathology.
Wagner BM
Hum Pathol; 1996 Oct; 27(10):1003-4. PubMed ID: 8892580
[No Abstract] [Full Text] [Related]
36. Toxicology in the 21st century--working our way towards a visionary reality.
Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
[TBL] [Abstract][Full Text] [Related]
37. Trouble shooting in toxicopathology.
Rousseaux CG
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):214-24. PubMed ID: 15987649
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers in translation; past, present and future.
Lock EA; Bonventre JV
Toxicology; 2008 Mar; 245(3):163-6. PubMed ID: 18272278
[TBL] [Abstract][Full Text] [Related]
39. Neurophysiological analysis of target-related sympathetic pathways--from animal to human: similarities and differences.
Jänig W; Häbler HJ
Acta Physiol Scand; 2003 Mar; 177(3):255-74. PubMed ID: 12608996
[TBL] [Abstract][Full Text] [Related]
40. The contribution of in vitro toxicity data in hazard and risk assessment: current limitations and future perspectives.
Blaauboer BJ
Toxicol Lett; 2008 Aug; 180(2):81-4. PubMed ID: 18586419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
